5

Camson Bio Technologies

538858 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 0.22 times its book value

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -49.4% over past five years.
  • Company has a low return on equity of -25.8% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 512 days.

Growth Rate

Revenue Growth
-48% lower than 3Y
Net Income Growth
-46% lower than 3Y

Quarterly Results

Particulars Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales
2.05
2.19
5.39
1.14
11.27
4.7
3.85
-0.51
1.29
1.52
1.58
0.59
1.19
Expenses
6.33
5.18
11.74
1.72
7.11
4.88
4.83
2.47
1.85
2.9
1.24
15.38
6.72
Operating Profit
-4.28
-2.99
-6.35
-0.58
4.16
-0.18
-0.98
-2.98
-0.56
-1.38
0.34
-14.79
-5.53
OPM %
-208.78%
-136.53%
-117.81%
-50.88%
36.91%
-3.83%
-25.45%
—
-43.41%
-90.79%
21.52%
-2506.78%
-464.71%
Other Income
0.53
0.59
0.58
0.22
0.69
0.62
0.23
-0.24
0
0.06
2.31
0.82
0
Interest
1.12
1.02
2.46
0.59
1.23
1.15
3.04
-0.06
1.73
2.27
2.11
-4.97
0.29
Depreciation
1.87
1.89
1.88
0.31
1.8
1.84
1.8
1.75
1.74
1.76
1.76
1.71
1.73
PBT
-6.74
-5.31
-10.11
-1.26
1.82
-2.55
-5.59
-4.91
-4.03
-5.35
-1.22
-10.71
-7.55
Tax %
2.52%
3.01%
-3.86%
0%
0%
0%
0%
0%
5.71%
6.36%
-46.72%
5.51%
0%
Net Profit
-6.91
-5.47
-9.72
-1.26
1.82
-2.55
-5.58
-4.9
-4.26
-5.69
-0.65
-11.3
-7.54
EPS in Rs
-2.3
-1.82
-3.24
-0.42
0.61
-0.85
-1.86
-1.63
-1.42
-1.9
-0.22
-3.77
-2.51
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales
33
39
65
85
95
117
140
157
24
9
18
5
5
Expenses
24
29
47
62
73
89
116
141
39
23
18
21
26
Operating Profit
9
10
18
23
22
28
25
16
-14
-13
0
-16
-21
OPM %
27%
25%
27%
26%
23%
24%
18%
10%
-59%
-141%
0.2%
-350%
-438%
Other Income
0
0
0
1
0
0
-3
6
1
4
1
3
3
Interest
0
0
0
0
0
2
4
4
5
7
5
1
0
Depreciation
1
1
2
1
2
3
5
13
22
7
7
7
7
PBT
8
8
16
22
20
23
13
5
-40
-23
-11
-21
-25
Tax %
3%
5%
7%
2%
-1%
0%
-5%
39%
-5%
-1%
0%
3%
—
Net Profit
8
8
15
22
21
23
13
3
-38
-23
-11
-22
-25
EPS in Rs
7.95
5.92
9.41
12.16
11.45
12.71
5.27
1.03
-12.61
-7.68
-3.74
-7.3
-8.4
Div. Payout %
0%
17%
11%
8%
9%
8%
19%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Equity Capital
10
14
16
18
18
18
25
30
30
30
30
30
Reserves
18
26
59
89
107
143
202
234
74
47
37
15
Borrowings
2
1
1
1
12
41
40
37
47
46
49
50
Other Liabilities
2
6
9
23
15
14
16
25
21
24
26
28
Total Liabilities
32
47
85
131
153
217
282
325
172
147
142
122
Fixed Assets
13
18
29
27
35
78
110
139
106
95
88
81
CWIP
0
0
6
11
22
0
0
0
0
0
0
0
Investments
0
0
1
4
0
0
0
0
6
3
3
3
Other Assets
19
28
50
89
96
138
173
187
60
49
50
37
Total Assets
32
47
85
131
153
217
282
325
172
147
142
122
Figures in ₹ Crores

Cash Flow

Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Operating
2
1
10
-2
10
-13
-15
14
-10
5
2
0
Investing
-6
-7
-19
-21
-20
-25
-36
-43
5
3
1
0
Financing
2
5
22
10
9
39
51
28
4
-7
-3
0
Net Cash Flow
-2
0
14
-13
-1
1
0
-1
0
0
0
0
Free Cash Flow
-4
-5
-7
-19
-10
-38
-51
-29
1
7
1
0
CFO/OP
19
12
59
-7
46
-48
-62
85
65
-35
6,100
0
Figures in ₹ Crores

Ratios

Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Debtor Days
54
69
66
182
180
199
218
342
249
145
101
512
Inventory Days
421
481
564
734
543
386
218
121
697
1,766
1,847
628
Days Payable
33
31
10
237
102
27
19
51
517
1,105
378
185
Cash Conversion Cycle
442
519
619
679
621
559
417
412
428
806
1,570
955
Working Capital Days
165
201
149
272
255
236
228
299
-437
-1,651
-322
-2,267
ROCE %
33%
24%
28%
24%
17%
15%
9%
3%
-15%
-12%
-5%
-19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Camson Bio Technologies insights

56 extracted metrics + investor summaries across FY08–FY26.

Log in — free

Shareholding Pattern

Public55.97%FIIs19.57%Promot.24.46%As ofSep 2019

Documents

Frequently Asked Questions about Camson Bio Technologies

What does Camson Bio Technologies Ltd do?
Camson Bio Technologies is engaged in the Business of Agricultural Biotech Products.
Where is Camson Bio Technologies Ltd (538858) listed?
Camson Bio Technologies Ltd trades under code 538858 on the BSE.
Which sector does Camson Bio Technologies Ltd belong to?
Camson Bio Technologies Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Camson Bio Technologies is engaged in the Business of Agricultural Biotech Products.

Website camsonbiotechnologies.com
Listed 2015-01-07
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538858.md for Camson Bio Technologies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List